GPT and metabolic dysfunction-associated steatotic liver disease: Famouri et al. (2017) reported a significant decrease in ALT levels from 47.3 ± 5.4 U/L to 36.4 ± 6.6 U/L (P = 0.015) in pediatric NAFLD patients [11].